Active cyamemazine metabolites in patients treated with cyamemazine (Tercian registered ): influence on cerebral dopamine D sub(2) and serotonin 5-HT sub(2A) receptor occupancy as measured by positron emission tomography (PET)
Rationale: Cyamemazine (Tercian registered ) is an antipsychotic agent blocking central dopamine D sub(2) receptors, which induces few extrapyramidal adverse effects, due to a potent antagonistic action at serotonin 5-HT sub(2A) receptors. In vitro studies showed that the desmethyl metabolite of cya...
Gespeichert in:
Veröffentlicht in: | Psychopharmacology 2011-10, Vol.217 (3), p.315-321 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!